Company / Cash per Share
Nuvation Bio Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.49
FY2025
5-year range
$0.16 / $669.18
FY2021-FY2025
Trend
+197.8%
vs FY2024
Sector context
#172 of 205
Health Care
What the data says
Nuvation Bio Inc.'s cash per share of $0.49 is lower than 84% of companies in the Health Care sector (FY2025). Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $0.49.
Based on SEC 10-K filings.
0.49 in FY2025 with a 5-year CAGR of +9.7%.
Declined from $194.85 to $0.49 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -89.9%
- 5-Year CAGR
- +9.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 205This company $0.49 Sector average $72.93
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 197.8% year-over-year.
- Ranks #172 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | +197.8% |
| FY2024 | $0.16 | -99.9% |
| FY2023 | $194.85 | -58.2% |
| FY2022 | $466.49 | -30.3% |
| FY2021 | $669.18 | +219243.3% |
| FY2020 | $0.31 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026